Showing results (1791-1800 of 2,383) with videos related to
Sort By:
Pageof 239
The American Journal of Managed Care|October 20, 2021
Reimbursement for genetic variant reinterpretation: five questions payers should askDavid L Veenstra, John W Rowe, José A Pagán, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1994
High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphomaC H Weaver, F B Petersen, F R Appelbaum, et al.The American Journal of Psychiatry|July 2, 2002
Capacity to provide informed consent for participation in schizophrenia and HIV researchDavid J Moser, Susan K Schultz, Stephan Arndt, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 21, 2006
Improving the efficacy of reduced intensity allogeneic transplantation for lymphoma using radioimmunotherapyAjay K Gopal, John M Pagel, Joseph G Rajendran, et al.Blood|May 10, 2011
A phase 2 study of lenalidomide monotherapy in patients with deletion 5q acute myeloid leukemia: Southwest Oncology Group Study S0605Mikkael A Sekeres, Holly Gundacker, Jeffrey Lancet, et al.Blood|May 26, 1999
Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugateE L Sievers, F R Appelbaum, R T Spielberger, et al.The New England Journal of Medicine|October 21, 1993
Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow supportO W Press, J F Eary, F R Appelbaum, et al.Transplantation|October 1, 1993
FK-506 and methotrexate prevent graft-versus-host disease in dogs given 9.2 Gy total body irradiation and marrow grafts from unrelated dog leukocyte antigen-nonidentical donorsR Storb, R F Raff, F R Appelbaum, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2015
Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Time to Move Toward a Minimal Residual Disease-Based Definition of Complete Remission?Daisuke Araki, Brent L Wood, Megan Othus, et al.Leukemia Research|February 7, 2018
Report of the relapsed/refractory cohort of SWOG S0919: A phase 2 study of idarubicin and cytarabine in combination with pravastatin for acute myelogenous leukemia (AML)Anjali S Advani, Hongli Li, Laura C Michaelis, et al.Pageof 239